FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Kuemmel, A; Single, K; Bittinger, F et al.
TA-MUC1 epitope in non-small cell lung cancer.Lung Cancer. Bd. 63. H. 1. 2009 S. 98-105
Waldner, M; Wirtz, SJ; Neurath, MF
Targeting Angiogenesis in Colitis-Associated CancerGASTROENTEROLOGY. Bd. 136. H. 5. 2009 S. A464-A464
Fritz, G
Targeting the mevalonate pathway for improved anticancer therapy.Curr Cancer Drug Targets. Bd. 9. H. 5. 2009 S. 626-38
Muller, P; Distler, E; Meyer, RG et al.
Targeting the programmed death (PD)-1/PD igand 1 pathway to induce peripheral tolerance in allograft recipientsBONE MARROW TRANSPLANTATION. Bd. 43. 2009 S. S302-S302
Muth, CM; Piepho, T; Tetzlaff, K
Tauchmedizinische Beratung für ReisendeFlugmedizin Tropenmedizin Reisemedizin. Bd. 16. H. 3. 2009 S. 131-137
Gockel, I; Timm, S; Musholt, TJ et al.
Technical aspects of laparoscopic Heller myotomy for achalasiaCHIRURG. Bd. 80. H. 9. 2009 S. 840-847
Naumann, SC; Roos, WP; Jost, E et al.
Temozolomide cells: response related to MGMT, MMR, DSBs, and p53Br J Cancer. Bd. 100. H. 2. 2009 S. 322-33
Thomke, F; Weilemann, S
Temporal dynamics of EEG patterns associated with generalized myoclonus after cardiopulmonary resuscitationEUROPEAN JOURNAL OF NEUROLOGY. Bd. 16. 2009 S. 199-199
Hess, G; Romaguera, J; Herbrecht, R et al.
TEMSIROLIMUS FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA: SUPPORTIVE EFFICACY ANALYSES FROM THE PHASE 3 STUDYHAEMATOLOGICA-THE HEMATOLOGY JOURNAL. Bd. 94. 2009 S. 391-392
Hess, G; Smith, SM; Berkenblit, A et al.
Temsirolimus in mantle cell lymphoma and other non-Hodgkin lymphoma subtypesSemin Oncol. Bd. S3. 2009 S. S37-45